欢迎来到天天文库
浏览记录
ID:34963183
大小:2.01 MB
页数:49页
时间:2019-03-15
《聚乙二醇干扰素联合恩替卡韦治疗hbeag阳性慢性乙型肝炎患者的临床观察》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、授予单位代码10089学号或申请号13829HebeiMedicalUniversity硕士学位论文在职科学学位聚乙二醇干扰素联合恩替卡韦治疗HBeAg阳性慢性乙型肝炎患者的临床观察研究生:李健导师:刘丽副教授专业:内科学二级学院:第二医院2015年3月河北医科大学学位论文使用授权及知识产权归属承诺本学位论文在导师(或指导小组)的指导下,由本人独立完成。本学位论文研究所获得的研究成果,其知识产权归河北医科大学所有。河北医科大学有权对本学位论文进行交流、公开和使用。凡发表与学位论文主要内容相关的论文,第一署名为
2、单位河北医科大学,试验材料、原始数据、申报的专利等知识产权均归河北医科大学所有。否则,承担相应法律责任。研究生签名:导师签章:二级学院领导盖章:_v年月日河北医科大学研究生学位论文独创性声明本论文是在导师指导下进行的研究工作及取得的研究成果,除了文中特别加以标注和致谢等内容外,文中不包含其他人已经发表或撰写的研究成果,指导教师对此进行了审定。本论文由本人独立撰写,文责自负。研究生签名:导师签章:目录中文摘要····················································
3、·····················································1英文摘要·········································································································3研究论文聚乙二醇干扰素联合恩替卡韦治疗HBeAg阳性慢性乙型肝炎患者的临床观察前言····················································
4、····················································6材料与方法·····························································································9结果·······································································································
5、··13附图·········································································································17附表·········································································································20讨论·································
6、········································································25结论·········································································································29参考文献······································································
7、···························29综述HBeAg阳性慢性乙型肝炎治疗方法研究进展······························34致谢·················································································································44个人简历····················································
8、·····················································45中文摘要聚乙二醇干扰素联合恩替卡韦治疗HBeAg阳性慢性乙型肝炎患者的临床观察摘要目的:观察并比较聚乙二醇干扰素、恩替卡韦及二者联合治疗HBeAg阳性的慢性乙型肝炎的疗效,为临床治疗提供依据。方法:选择2011年5月~2013年10月在我院治疗的符合2011年修订的慢性乙型肝炎防治指南的诊断
此文档下载收益归作者所有